Nature Communications (Oct 2024)
Author Correction: Targeting HDAC6 to treat heart failure with preserved ejection fraction in mice
- Sara Ranjbarvaziri,
- Aliya Zeng,
- Iris Wu,
- Amara Greer-Short,
- Farshad Farshidfar,
- Ana Budan,
- Emma Xu,
- Reva Shenwai,
- Matthew Kozubov,
- Cindy Li,
- Melissa Van Pell,
- Francis Grafton,
- Charles E MacKay,
- Xiaomei Song,
- James R Priest,
- Gretchen Argast,
- Mohammad A. Mandegar,
- Timothy Hoey,
- Jin Yang
Affiliations
- Sara Ranjbarvaziri
- Tenaya Therapeutics
- Aliya Zeng
- Tenaya Therapeutics
- Iris Wu
- Tenaya Therapeutics
- Amara Greer-Short
- Tenaya Therapeutics
- Farshad Farshidfar
- Tenaya Therapeutics
- Ana Budan
- Tenaya Therapeutics
- Emma Xu
- Tenaya Therapeutics
- Reva Shenwai
- Tenaya Therapeutics
- Matthew Kozubov
- Tenaya Therapeutics
- Cindy Li
- Tenaya Therapeutics
- Melissa Van Pell
- Tenaya Therapeutics
- Francis Grafton
- Tenaya Therapeutics
- Charles E MacKay
- Tenaya Therapeutics
- Xiaomei Song
- Tenaya Therapeutics
- James R Priest
- Tenaya Therapeutics
- Gretchen Argast
- Tenaya Therapeutics
- Mohammad A. Mandegar
- Tenaya Therapeutics
- Timothy Hoey
- Tenaya Therapeutics
- Jin Yang
- Tenaya Therapeutics
- DOI
- https://doi.org/10.1038/s41467-024-52831-3
- Journal volume & issue
-
Vol. 15,
no. 1
pp. 1 – 2
Abstract
No abstracts available.
